Darunavir (Prezista)

Published August 09, 2006; Updated October 19, 2011
Susa Coffey, MD
Selected References
4. Darunavir [package insert]. East Bridgewater, NJ: Tibotec Therapeutics: 2010; update forthcoming.
10. De Meyer S, A Hill, De Baere I, et al. Effect of Baseline Susceptibility and On-treatment Mutations on TMC114 and Control PI Efficacy: Preliminary Analysis of Data from PI-experienced Patients from POWER 1 and POWER 2. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections; February 5-9, 2006; Denver. Abstract 157.